List of bibliographic references indexed by Dyskinesia, Drug-Induced (drug therapy)
Number of relevant bibliographic references: 27.
[0-20] [
0 - 20][
0 - 27][
20-26][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000165 (2016) |
Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France] | Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia. |
| 000253 (2016) |
Matthieu F. Bastide [France] ; Brice De La Crompe [France] ; Evelyne Doudnikoff [France] ; Pierre-Olivier Fernagut [France] ; Christian E. Gross [France] ; Nicolas Mallet [France] ; Thomas Boraud [France] ; Erwan Bézard [France] | Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia. |
| 000354 (2016) |
Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie] | Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. |
| 000515 (2015) |
Emma D. Deeks [Oman] | Safinamide: first global approval. |
| 000562 (2015) |
Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal] | New treatments for levodopa-induced motor complications. |
| 000573 (2015) |
H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis] | NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat. |
| 000622 (2015) |
Mariza Bortolanza [Brésil] ; Roberta Cavalcanti-Kiwiatkoski [Brésil] ; Fernando E. Padovan-Neto [Brésil] ; Célia Aparecida Da-Silva [Brésil] ; Miso Mitkovski [Allemagne] ; Rita Raisman-Vozari [France] ; Elaine Del-Bel [Brésil] | Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease. |
| 000651 (2015) |
C. Fidalgo [Italie] ; W K D. Ko [Royaume-Uni] ; E. Tronci [Italie] ; Q. Li [République populaire de Chine] ; R. Stancampiano [Italie] ; Q. Chuan [République populaire de Chine] ; E. Bezard [République populaire de Chine] ; M. Carta [Italie] | Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. |
| 000676 (2015) |
Erwan Bezard [France] ; Manolo Carta [Italie] | Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease? |
| 000808 (2014) |
Fabienne Ory-Magne [France] ; Jean-Christophe Corvol ; Jean-Philippe Azulay ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Philippe Damier ; Estelle Dellapina ; Alain Destée [France] ; Franck Durif ; Monique Galitzky ; Thibaud Lebouvier ; Wassilios Meissner ; Claire Thalamas ; François Tison ; Alexandrine Salis ; Agnès Sommet ; François Viallet ; Marie Vidailhet ; Olivier Rascol | Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. |
| 000A28 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 000C23 (2013) |
Khaled-Ezaheir Bennouar [France] ; Michelle A. Uberti ; Christophe Melon ; Maria D. Bacolod ; Hermogenes N. Jimenez ; Manuel Cajina ; Lydia Kerkerian-Le Goff ; Darío Doller ; Paolo Gubellini | Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia. |
| 000C35 (2013) |
François Tison [France] ; Laurence Nègre-Pagès ; Wassilios G. Meissner ; Sandrine Dupouy ; Qin Li ; Marie-Laure Thiolat ; Thibaud Thiollier ; Monique Galitzky ; Fabienne Ory-Magne ; Agathe Milhet ; Laurent Marquine ; Umberto Spampinato ; Olivier Rascol ; Erwan Bezard | Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients. |
| 000D14 (2013) |
M. Amalric [France] ; S. Lopez ; C. Goudet ; G. Fisone ; G. Battaglia ; F. Nicoletti ; J-P Pin ; F C Acher | Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease. |
| 000D73 (2013) |
Erwan Bézard [République populaire de Chine] ; Ana Mu Oz ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. |
| 000E27 (2013) |
Erwan Bezard [France, République populaire de Chine] ; Elisabetta Tronci [Italie, Suède] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Gregory Porras [Royaume-Uni] ; Anders Björklund [Suède] ; Manolo Carta [Italie, Suède] | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia |
| 001389 (2012) |
P. De Deurwaerdere [France] ; S. Navailles [France] | What can we expect from the serotonergic side of L-DOPA? |
| 001723 (2011) |
O. Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
| 002E49 (2004) |
F. Durif [France] ; B. Debilly ; M. Galitzky ; D. Morand ; F. Viallet ; M. Borg ; S. Thobois ; E. Broussolle ; O. Rascol | Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study. |
| 003576 (2001) |
E. Bezard [France] ; J M Brotchie ; C E Gross | Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. |
| 003828 (2001) |
O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dyskinesia, Drug-Induced (drug therapy)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Dyskinesia, Drug-Induced (drug therapy)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Dyskinesia, Drug-Induced (drug therapy)
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
